StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/302% above fair value
$14.35+0.29 (+2.06%)

Close on Nov 20, 2026Market cap $285.81MP/E 35.0Yield –

InfuSystem gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

InfuSystem's gross profit for the twelve months ending Jun 30, 2026 was $82.35M, up 7.9% year over year. For fiscal 2025 it was $80.30M, up 14.1% from the year before. Over ten years it grew 4.9% a year on average. The highest annual figure on record is $80.30M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$80.30M+14.1%
FY2024Dec 31, 2024$70.40M+11.6%
FY2023Dec 31, 2023$63.11M+4.2%
FY2022Dec 31, 2022$60.56M+3.5%
FY2021Dec 31, 2021$58.54M-0.4%
FY2020Dec 31, 2020$58.76M+25.3%
FY2019Dec 31, 2019$46.88M+18.5%
FY2018Dec 31, 2018$39.57M-8.7%
FY2017Dec 31, 2017$43.36M-3.1%
FY2016Dec 31, 2016$44.74M-9.8%
FY2015Dec 31, 2015$49.60M+4.7%
FY2014Dec 31, 2014$47.35M+8.4%
FY2013Dec 31, 2013$43.68M+1.8%
FY2012Dec 31, 2012$42.91M+21.4%
FY2011Dec 31, 2011$35.36M+5.4%
FY2010Dec 31, 2010$33.55M+17.1%
FY2009Dec 31, 2009$28.64M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$21.41M+7.7%
Q1 FY2026Mar 31, 2026$19.68M+2.7%
Q4 FY2025Dec 31, 2025$20.44M+12.2%
Q3 FY2025Sep 30, 2025$20.82M+9.3%
Q2 FY2025Jun 30, 2025$19.87M+19.2%
Q1 FY2025Mar 31, 2025$19.17M+16.3%
Q4 FY2024Dec 31, 2024$18.22M+9.0%
Q3 FY2024Sep 30, 2024$19.05M+22.0%
Q2 FY2024Jun 30, 2024$16.67M+5.3%
Q1 FY2024Mar 31, 2024$16.47M+10.2%
Q4 FY2023Dec 31, 2023$16.71M+18.7%
Q3 FY2023Sep 30, 2023$15.62M-3.7%
Q2 FY2023Jun 30, 2023$15.83M+6.2%
Q1 FY2023Mar 31, 2023$14.95M-2.7%
Q4 FY2022Dec 31, 2022$14.07M+3.1%
Q3 FY2022Sep 30, 2022$16.22M+6.3%
Q2 FY2022Jun 30, 2022$14.90M-1.0%
Q1 FY2022Mar 31, 2022$15.37M+5.4%
Q4 FY2021Dec 31, 2021$13.65M-9.0%
Q3 FY2021Sep 30, 2021$15.26M+0.9%
Q2 FY2021Jun 30, 2021$15.05M-5.8%
Q1 FY2021Mar 31, 2021$14.58M+15.1%
Q4 FY2020Dec 31, 2020$15.00M+15.8%
Q3 FY2020Sep 30, 2020$15.12M+23.6%
Q2 FY2020Jun 30, 2020$15.98M+40.7%
Q1 FY2020Mar 31, 2020$12.66M+22.5%
Q4 FY2019Dec 31, 2019$12.95M+29.8%
Q3 FY2019Sep 30, 2019$12.24M+26.5%
Q2 FY2019Jun 30, 2019$11.36M+17.2%
Q1 FY2019Mar 31, 2019$10.34M+1.0%
Q4 FY2018Dec 31, 2018$9.97M-12.0%
Q3 FY2018Sep 30, 2018$9.67M-12.4%
Q2 FY2018Jun 30, 2018$9.69M-6.3%
Q1 FY2018Mar 31, 2018$10.24M-3.9%
Q4 FY2017Dec 31, 2017$11.33M+6.4%
Q3 FY2017Sep 30, 2017$11.04M+6.3%
Q2 FY2017Jun 30, 2017$10.34M–
Q1 FY2017Mar 31, 2017$10.65M–
Q4 FY2016Dec 31, 2016$10.65M–
Q3 FY2016Sep 30, 2016$10.39M–

More InfuSystem figures

See a number that looks wrong?